{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:07:47Z","timestamp":1784246867633,"version":"3.55.0"},"reference-count":63,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Unrestricted Grant from Research to Prevent Blindness, Inc.","award":["NIH K01OD034451"],"award-info":[{"award-number":["NIH K01OD034451"]}]},{"name":"Pooled Professors Fund at the Wilmer Eye Institute, Johns Hopkins University, School of Medicine"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["IJMS"],"abstract":"<jats:p>Ocular adnexal sebaceous carcinoma (SebCA) represents one of the most clinically problematic periocular tumors, often requiring aggressive surgical resection. The pathobiology of this tumor remains poorly understood, and few models exist that are suitable for preclinical testing. The aim of this study was to establish new cell lines to serve as models for pathobiological and drug testing. With patient consent, freshly resected tumor tissue was cultured using conditional reprogramming cell conditions. Standard techniques were used to characterize the cell lines in terms of overall growth, clonogenicity, apoptosis, and differentiation in vitro. Additional analyses including Western blotting, short tandem repeat (STR) profiling, and next-generation sequencing (NGS) were performed. Drug screening using mitomycin-C (MMC), 5-fluorouricil (5-FU), and 6-Diazo-5-oxo-L-norleucine (DON) were performed. JHH-SebCA01, JHH-SebCA02, and JHH-SebCA03 cell lines were established from two women and one man undergoing surgical resection of eyelid tumors. At passage 15, they each showed a doubling time of two to three days, and all could form colonies in anchorage-dependent conditions, but not in soft agar. The cells contained cytoplasmic vacuoles consistent with sebaceous differentiation, and adipophilin protein was present in all three lines. STR profiling confirmed that all lines were derived from their respective patients. NGS of the primary tumors and their matched cell lines identified numerous shared mutations, including alterations similar to those previously described in SebCA. Treatment with MMC or 5-FU resulted in dose-dependent growth inhibition and the induction of both apoptosis and differentiation. MYC protein was abundant in all three lines, and the glutamine metabolism inhibitor DON, previously shown to target high MYC tumors, slowed the growth of all our SebCA models. Ocular adnexal SebCA cell lines can be established using conditional reprogramming cell conditions, and our three new models are useful for testing therapies and interrogating the functional role of MYC and other possible molecular drivers. Current topical chemotherapies promote both apoptosis and differentiation in SebCA cells, and these tumors appear sensitive to inhibition or MYC-associated metabolic changes.<\/jats:p>","DOI":"10.3390\/ijms251810183","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T03:36:38Z","timestamp":1727062598000},"page":"10183","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Establishment and Characterization of Three Human Ocular Adnexal Sebaceous Carcinoma Cell Lines"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9929-9521","authenticated-orcid":false,"given":"Su-Chan","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6550-1883","authenticated-orcid":false,"given":"Cornelia","family":"Peterson","sequence":"additional","affiliation":[{"name":"Department of Comparative Pathobiology, Tufts University Cummings School of Veterinary Medicine, North Grafton, MA 01536, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujain","family":"Alaali","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA"},{"name":"Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Eshleman","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Mahoney","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Eberhart","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA"},{"name":"Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5420-3411","authenticated-orcid":false,"given":"Ashley A.","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0046-8177(82)80115-9","article-title":"Sebaceous carcinomas of the ocular adnexa: A clinicopathologic study of 104 cases, with five-year follow-up data","volume":"13","author":"Rao","year":"1982","journal-title":"Hum. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.sjopt.2013.05.002","article-title":"Periocular sebaceous gland carcinoma: A comprehensive review","volume":"27","author":"Mulay","year":"2013","journal-title":"Saudi J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/ICU.0000000000000505","article-title":"Current review of sebaceous cell carcinoma","volume":"29","author":"Orr","year":"2018","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/bjophthalmol-2018-312635","article-title":"Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: Observations in 100 patients","volume":"103","author":"Sa","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.eye.6700523","article-title":"Improved survival rates in sebaceous carcinoma of the eyelid","volume":"18","author":"Muqit","year":"2004","journal-title":"Eye"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/dsu.12433","article-title":"Characteristics of Sebaceous Carcinoma and Early Outcomes of Treatment Using Mohs Micrographic Surgery Versus Wide Local Excision: An Update of the Mayo Clinic Experience Over the Past 2 Decades","volume":"40","author":"Hou","year":"2014","journal-title":"Dermatol. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0039-6257(89)90049-0","article-title":"Sebaceous carcinoma of the ocular adnexa","volume":"33","author":"Kass","year":"1989","journal-title":"Surv. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.survophthal.2004.12.008","article-title":"Sebaceous carcinoma of the ocular region: A review","volume":"50","author":"Shields","year":"2005","journal-title":"Surv. Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/DAD.0b013e3181961861","article-title":"Clinicopathological features of eyelid skin tumors. A retrospective study of 5504 cases and review of literature","volume":"31","author":"Deprez","year":"2009","journal-title":"Am. J. Dermatopathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100227","DOI":"10.1016\/j.xops.2022.100227","article-title":"Prevalence of and Associated Factors for Eyelid Cancer in the American Academy of Ophthalmology Intelligent Research in Sight Registry","volume":"3","author":"Sharpe","year":"2023","journal-title":"Ophthalmol. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000439308","article-title":"Expression of p16 and p53 in Intraepithelial Periocular Sebaceous Carcinoma","volume":"2","author":"Bell","year":"2016","journal-title":"Ocul. Oncol. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1158\/1078-0432.CCR-18-1688","article-title":"Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus- Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations","volume":"15","author":"Tetzlaff","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/iovs.09-4127","article-title":"Analysis of p53 Mutations and the Expression of p53 and p21WAF1\/CIP1Protein in 15 Cases of Sebaceous Carcinoma of the Eyelid","volume":"51","author":"Kiyosaki","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-9570.1000635","article-title":"Clinical and Immunohistochemical Features of Sebaceous Carcinoma: Focusing on the p53 Tumor Suppressor","volume":"8","author":"Singh","year":"2017","journal-title":"J. Clin. Exp. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jgg.2019.06.001","article-title":"Mutations in TP53, ZNF750, and RB1 typify ocular sebaceous carcinoma","volume":"46","author":"Bao","year":"2019","journal-title":"J. Genet. Genom."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/DAD.0b013e3181ed39f9","article-title":"p53 Staining Correlates With Tumor Type and Location in Sebaceous Neoplasms","volume":"34","author":"Shalin","year":"2012","journal-title":"Am. J. Dermatopathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0161-6420(98)93034-2","article-title":"Sebaceous carcinoma: Tumor progression through mutational inactivation of p53","volume":"105","author":"Kaltreider","year":"1998","journal-title":"Ophthalmology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/IOP.0000000000000121","article-title":"UV-Independent p53 Mutations in Sebaceous Carcinoma of the Eyelid","volume":"30","author":"Hussain","year":"2014","journal-title":"Ophthalmic. Plast. Reconstr. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/cup.13987","article-title":"High-Risk Human Papillomavirus and ZEB1 in Ocular Adnexal Sebaceous Carcinoma","volume":"48","author":"Moore","year":"2021","journal-title":"J. Cutan. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2559.2009.03454.x","article-title":"Sebaceous neoplasia and the Muir-Torre syndrome: Important connections with clinical implications","volume":"56","author":"Shalin","year":"2010","journal-title":"Histopathology"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Tomonari, M., Shimada, M., Nakada, Y., Yamamoto, I., Itoh, M., Koike, Y., Kobayashi, A., Miki, J., Yamada, H., and Kimura, T. (2019). Muir\u2013Torre syndrome: Sebaceous carcinoma concurrent with colon cancer in a kidney transplant recipient; a case report. BMC Nephrol., 20.","DOI":"10.1186\/s12882-019-1592-7"},{"key":"ref_22","first-page":"252","article-title":"Muir-Torre syndrome: A rare but important disorder","volume":"82","author":"Hare","year":"2008","journal-title":"Cutis"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/PGP.0000000000000572","article-title":"Muir-Torre Syndrome With a Frame-shift Mutation in the MSH2 Gene: A Rare Case Report and Literature Review","volume":"39","author":"Chen","year":"2020","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/j.1572-0241.1998.00487.x","article-title":"The Muir-Torre syndrome: A rare variant of hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation","volume":"93","author":"Suspiro","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/jhg.2009.119","article-title":"A novel complex mutation in MSH2 contributes to both Muir-Torre and Lynch Syndrome","volume":"55","author":"Perera","year":"2010","journal-title":"J. Hum. Genet."},{"key":"ref_26","first-page":"1784","article-title":"Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome","volume":"6","author":"Entius","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Peterson, C., Moore, R., Hicks, J.L., Morsberger, L.A., De Marzo, A.M., Zou, Y., Eberhart, C.G., and Campbell, A.A. (2021). NGS Analysis Confirms Common TP53 and RB1 Mutations, and Suggests MYC Amplification in Ocular Adnexal Sebaceous Carcinomas. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168454"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jaad.2016.07.046","article-title":"Incidence and survival of sebaceous carcinoma in the United States","volume":"75","author":"Tripathi","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1167\/tvst.10.6.34","article-title":"Establishment and Characterization of a Novel Human Ocular Adnexal Sebaceous Carcinoma Cell Line","volume":"10","author":"Rong","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ophtha.2004.07.031","article-title":"Sebaceous carcinoma of the eyelids: Personal experience with 60 cases","volume":"111","author":"Shields","year":"2004","journal-title":"Ophthalmology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ophtha.2011.11.006","article-title":"American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival","volume":"119","author":"Esmaeli","year":"2012","journal-title":"Ophthalmology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/IOP.0b013e31816d925f","article-title":"Sebaceous cell carcinoma of the ocular adnexa: Clinical presentations, histopathology, and outcomes","volume":"24","author":"Song","year":"2008","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000210927","article-title":"Culture of human sebocytes and markers of sebocytic differentiation in vitro","volume":"4","author":"Zouboulis","year":"1991","journal-title":"Skin Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4161\/derm.1.2.8736","article-title":"Culture of human sebocytes in vitro","volume":"1","author":"Xia","year":"2009","journal-title":"Dermato-Endocrinology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1167\/iovs.09-5108","article-title":"Culture, Immortalization, and Characterization of Human Meibomian Gland Epithelial Cells","volume":"51","author":"Liu","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ajo.2021.12.016","article-title":"Effects of Mitomycin-C and 5-Fluorouracil on Ocular Adnexal Sebaceous Carcinoma Cells","volume":"240","author":"Gallo","year":"2022","journal-title":"Am. J. Ophthalmol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"517","DOI":"10.21037\/atm-21-3897","article-title":"Overexpression of miR-651-5p inhibits ultraviolet radiation-induced malignant biological behaviors of sebaceous gland carcinoma cells by targeting ZEB2","volume":"10","author":"Zhao","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1365-2133.2005.06458.x","article-title":"Ectopic expression of c-Myc in the skin affects the hair growth cycle and causes an enlargement of the sebaceous gland","volume":"152","author":"Bull","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/neup.12534","article-title":"Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high-MYC medulloblastoma","volume":"39","author":"Natsumeda","year":"2019","journal-title":"Neuropathology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13046-023-02790-2","article-title":"MYC up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastoma","volume":"42","author":"Pitolli","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1128\/MCB.01442-07","article-title":"Chromatin-Bound p53 Anchors Activated Smads and the mSin3A Corepressor To Confer Transforming Growth Factor \u03b2-Mediated Transcription Repression","volume":"28","author":"Wilkinson","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/jnen\/nlab018","article-title":"Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis","volume":"80","author":"Pham","year":"2021","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1158\/1078-0432.CCR-19-0189","article-title":"Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid\/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine","volume":"25","author":"Wang","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajo.2024.07.036","article-title":"Eyelid\/Periocular Sebaceous Gland Carcinoma in 500 Eyes: Analysis based on 8th Edition American Joint Cancer Committee Classification","volume":"269","author":"Vempuluru","year":"2024","journal-title":"Am. J. Ophthalmol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/ijd.17045","article-title":"Periocular sebaceous carcinoma: Updates in the diagnosis, treatment, staging, and management","volume":"63","author":"Dini","year":"2024","journal-title":"Int. J. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/iovs.64.15.16","article-title":"Establishment and Characterization of a TP53-Mutated Eyelid Sebaceous Carcinoma Cell Line","volume":"64","author":"Gu","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ajpath.2011.10.036","article-title":"ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells","volume":"180","author":"Liu","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/neuonc\/noaa263","article-title":"Conditional reprogramming culture conditions facilitate growth of lower-grade glioma models","volume":"23","author":"Yuan","year":"2021","journal-title":"Neuro-Oncology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/path.4759","article-title":"Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma","volume":"240","author":"Tetzlaff","year":"2016","journal-title":"J. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1158\/0008-5472.CAN-06-2314","article-title":"Drosophila split ends homologue SHARP functions as a positive regulator of Wnt\/beta-catenin\/T-cell factor signaling in neoplastic transformation","volume":"67","author":"Feng","year":"2007","journal-title":"Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2147\/OTT.S200317","article-title":"SPOCD1 accelerates ovarian cancer progression and inhibits cell apoptosis via the PI3K\/AKT pathway","volume":"13","author":"Liu","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41419-020-2699-2","article-title":"SPEN induces miR-4652-3p to target HIPK2 in nasopharyngeal carcinoma","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e1539","DOI":"10.1002\/wsbm.1539","article-title":"The tumor immune microenvironments of HPV+ and HPV- head and neck cancers","volume":"14","author":"Gameiro","year":"2022","journal-title":"WIREs Mech. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/DAD.0000000000000255","article-title":"Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: A clinicopathologic and immunohistochemical study","volume":"37","author":"Plaza","year":"2015","journal-title":"Am. J. Dermatopathol."},{"key":"ref_55","first-page":"3088","article-title":"Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta","volume":"8","author":"Coffey","year":"1988","journal-title":"Mol. Cell. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0006-291X(91)90518-C","article-title":"Growth inhibition of human keratinocytes by antisense c-myc oligomer is not coupled to induction of differentiation","volume":"174","author":"Hashiro","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1167\/iovs.12-10671","article-title":"Expression of Shh and Wnt signaling pathway proteins in eyelid sebaceous gland carcinoma: Clinicopathologic study","volume":"54","author":"Kim","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"105805","DOI":"10.1016\/j.isci.2022.105805","article-title":"Distinct bulge stem cell populations maintain the pilosebaceous unit in a \u03b2-catenin-dependent manner","volume":"26","author":"Han","year":"2023","journal-title":"iScience"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1158\/0008-5472.CAN-18-1787","article-title":"MYC Drives Group 3 Medulloblastoma through Transformation of Sox2+ Astrocyte Progenitor Cells","volume":"79","author":"Tao","year":"2019","journal-title":"Cancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00401-019-02020-0","article-title":"Second-generation molecular subgrouping of medulloblastoma: An international meta-analysis of Group 3 and Group 4 subtypes","volume":"138","author":"Sharma","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"18782","DOI":"10.1073\/pnas.0810199105","article-title":"Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction","volume":"105","author":"Wise","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature07823","article-title":"c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism","volume":"458","author":"Gao","year":"2009","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Tambay, V., Raymond, V.-A., and Bilodeau, M. (2021). MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype. Cancers, 13.","DOI":"10.3390\/cancers13174484"}],"updated-by":[{"DOI":"10.3390\/ijms26189147","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000}}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/18\/10183\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T12:34:03Z","timestamp":1758285243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/18\/10183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":63,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["ijms251810183"],"URL":"https:\/\/doi.org\/10.3390\/ijms251810183","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]}}}